UnitedHealthcare coverage policies

UHC-POL-COMM-Laboratory-Services-Policy

Laboratory Services Policy, Professional

UHC-PROT-LABORATORY-SERVICES

Laboratory Services Protocol - M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred

UHC-POL-lemtrada-alemtuzumab

Lemtrada (Alemtuzumab)

Effective Apr 1, 2026

UHC-EXCH-MD-LEMTRADA-ALEMTUZUMAB

Lemtrada (Alemtuzumab) – Commercial and Individual Exchange Medical Benefit Drug Policy

UHC-COMM-MD-LEMTRADA-ALEMTUZUMAB-CS

Lemtrada (Alemtuzumab) – Community Plan Medical Benefit Drug Policy

UHC-POL-leqembi

Leqembi (Lecanemab-Irmb)

Effective Apr 1, 2026

UHC-EXCH-MD-LEQEMBI-LECANEMAB-IRMB-IEX

Leqembi (Lecanemab-Irmb) – Individual Exchange Medical Benefit Drug Policy

UHC-POL-leqvio

Leqvio (Inclisiran)

Effective Jun 1, 2026

UHC-COMM-MD-LEQVIO-INCLISIRAN-CS

Leqvio (Inclisiran) – Community Plan Medical Benefit Drug Policy

UHC-EXCH-MD-LEQVIO-INCLISIRAN-IEX

Leqvio (Inclisiran) – Individual Exchange Medical Benefit Drug Policy

UHC-COMM-MD-LIGHT-LASER-THERAPY-CS

Light and Laser Therapy

UHC-EXCH-MD-LIGHT-LASER-THERAPY

Light and Laser Therapy

UHC-POL-light-laser-therapy

Light and Laser Therapy

Effective Jan 1, 2026

UHC-COMM-MD-LIPOSUCTION-FOR-LIPEDEMA-CS

Liposuction for Lipedema

UHC-EXCH-MD-LIPOSUCTION-LIPEDEMA

Liposuction for Lipedema

UHC-POL-liposuction-lipedema

Liposuction for Lipedema

Effective Jan 1, 2026

UHC-POL-long-acting-injectable-antiretroviral-agents

Long-Acting Injectable Antiretroviral Agents for HIV

Effective Oct 1, 2026

UHC-COMM-MD-LONG-ACTING-INJECTABLE-ANTIRETROVIRAL-AGENTS-CS

Long-Acting Injectable Antiretroviral Agents for HIV – Community Plan Medical Benefit Drug Policy

UHC-EXCH-MD-LONG-ACTING-INJECTABLE-ANTIRETROVIRAL-AGENTS-IEX

Long-Acting Injectable Antiretroviral Agents for HIV – Individual Exchange Medical Benefit Drug Policy

UHC-COMM-MD-LOWER-EXTREMITY-VASCULAR-ANGIOGRAPHY-CS

Lower Extremity Endovascular Procedures

UHC-EXCH-MD-LOWER-ENDOVASCULAR-PROCEDURES

Lower Extremity Endovascular Procedures

UHC-POL-lower-endovascular-procedures

Lower Extremity Endovascular Procedures

Effective Oct 1, 2026

UHC-COMM-MD-LOWER-EXTREMITY-PROSTHETICS-CS

Lower Extremity Prosthetics

UHC-EXCH-MD-LOWER-EXTREMITY-PROSTHETICS

Lower Extremity Prosthetics

UHC-POL-lower-extremity-prosthetics

Lower Extremity Prosthetics

Effective Aug 1, 2026

UHC-POL-lumvoa-tepezza

Lumvoa (Veligrotug-Vvze) and Tepezza (Teprotumumab-Trbw)

Effective Oct 1, 2026

UHC-POL-luxturna-voretigene-neparvovec-rzyl

Luxturna (Voretigene Neparvovec-Rzyl)

Effective Oct 1, 2026

UHC-COMM-MD-LUXTURNA-VORETIGENE-NEPARVOVEC-RZYL-CS

Luxturna (Voretigene Neparvovec-Rzyl) – Community Plan Medical Benefit Drug Policy

UHC-EXCH-MD-LUXTURNA-VORETIGENE-NEPARVOVEC-RZYL-IEX

Luxturna (Voretigene Neparvovec-Rzyl) – Individual Exchange Medical Benefit Drug Policy

UHC-COMM-RP-UHCCP-LYME-DISEASE-TESTING-POLICY-PROFESSIONAL-FACILITY

Lyme Disease Testing Policy, Professional and Facility

UHC-EXCH-RP-COMM-IEX-LYME-DISEASE-TESTING-POLICY-PROFESSIONAL-FACILITY

Lyme Disease Testing Policy, Professional and Facility

UHC-POL-COMM-IEX-Lyme-Disease-Testing-Policy-Professional-Facility

Lyme Disease Testing Policy, Professional and Facility

UHC-EXCH-MD-MRI-CT-SCAN-SITE-OF-SERVICE

Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Service

UHC-POL-mri-ct-scan-site-of-service

Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Service

Effective Sep 1, 2026

UHC-COMM-MD-MANDATORY-MEDICAID-COVERAGE-QUALIFYING-CLINICAL-TRIALS-CS

Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials

UHC-COMM-MD-MANIPULATION-UNDER-ANESTHESIA-CS

Manipulation Under Anesthesia

UHC-EXCH-MD-MANIPULATION-UNDER-ANESTHESIA

Manipulation Under Anesthesia

UHC-POL-manipulation-under-anesthesia

Manipulation Under Anesthesia

Effective Feb 1, 2026

UHC-COMM-MD-MANIPULATIVE-THERAPY-CS

Manipulative Therapy

UHC-EXCH-MD-MANIPULATIVE-THERAPY

Manipulative Therapy